Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Grossman, E.
space
  arrow  Messerli, F. H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

Diabetic and Hypertensive Heart Disease

right arrow Ehud Grossman, MD, and Franz H. Messerli, MD

15 August 1996 | Volume 125 Issue 4 | Pages 304-310

Objective: To review the literature on the cardiac effects of diabetes mellitus and hypertension.

Data Sources: A MEDLINE search of English-language articles published between 1980 and January 1996 was done using the terms diabetes mellitus, hypertension or blood pressure, and heart. References cited in identified articles were also reviewed.

Study Selection: Selected studies were divided into those addressing coronary artery disease or myocardial ischemia and those addressing nonischemic cardiomyopathy and its sequelae. Preference was given to articles about the cardiac complications of both diabetes mellitus and hypertension.

Results: Patients with diabetes and hypertension have a higher incidence of coronary artery disease than do patients with diabetes or hypertension alone. The former patients also show impaired systolic and diastolic function and have more severe left ventricular hypertrophy as documented by echocardiography and at autopsy. The structural myocardial damage seen in these patients has been attributed primarily to hypertension; the myocellular dysfunction has been attributed primarily to diabetes. In diabetic hypertensive patients with cardiomyopathy, coronary artery disease as well as structural and functional cardiac abnormalities are more pronounced than would be expected from either diabetes or hypertension alone.

Conclusions: Considerable evidence from both experimental animal models and humans points to hypertension as a critically important factor in the pathogenesis of severe heart disease in persons with diabetes. The pathogenetic sequelae of diabetes and hypertension are devastating to the heart and often lead to premature congestive heart failure, sudden cardiac death, and acute myocardial infarction. Strict control of arterial pressure and glycemia may prevent or even ameliorate heart disease in patients with hypertension and diabetes.

Author and Article Information
space

From The Chaim Sheba Medical Center, Tel-Hashomer, Israel; and the Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana.
Current Author Addresses: Dr. Grossman: Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, 52621 Israel.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn
Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects
Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H.-C. Lai, T.-J. Liu, C.-T. Ting, J.-Y. Yang, L. Huang, D. Wallace, P. Kaiser, and P. H. Wang
Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E292 - E297.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
R. Negro and H. Hassan
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 243 - 246.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. T. Vlagopoulos, H. Tighiouart, D. E. Weiner, J. Griffith, D. Pettitt, D. N. Salem, A. S. Levey, and M. J. Sarnak
Anemia as a Risk Factor for Cardiovascular Disease and All-Cause Mortality in Diabetes: The Impact of Chronic Kidney Disease
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3403 - 3410.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-S. Chen, Y.-X. Shan, T.-L. Yang, H.-D. Lin, J.-W. Chen, S.-J. Lin, and P. H. Wang
Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium
Diabetes, January 1, 2005; 54(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. I. Karvounis, C. E. Papadopoulos, T. A. Zaglavara, I. G. Nouskas, K. D. Gemitzis, G. E. Parharidis, and G. E. Louridas
Evidence of Left Ventricular Dysfunction in Asymptomatic Elderly Patients with Non-insulin-dependent Diabetes Mellitus
Angiology, September 1, 2004; 55(5): 549 - 555.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev., August 1, 2004; 25(4): 543 - 567.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
A Tracqui, A Miras, A Tabib, J S Raul, B Ludes, and D Malicier
Fatal overdosage with sildenafil citrate (Viagra1): first report and review of the literature
Human and Experimental Toxicology, November 1, 2002; 21(11): 623 - 629.
[Abstract] [PDF]


Home page
ChestHome page
R. C. Sampaio, J. E. Tanus-Santos, S. E. S. F. C. Melo, S. Hyslop, K. G. Franchini, I. M. Luca, and H. Moreno Jr
Hypertension Plus Diabetes Mimics the Cardiomyopathy Induced by Nitric Oxide Inhibition in Rats
Chest, October 1, 2002; 122(4): 1412 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. Eriksson, J. Lindstrom, and J. Tuomilehto
Potential for the prevention of type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 183 - 199.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. C. Fonarow
Quality Indicators for the Management of Heart Failure in Vulnerable Elders
Ann Intern Med, October 16, 2001; 135(8_Part_2): 694 - 702.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A Mosterd, B Cost, A.W Hoes, M.C de Bruijne, J.W Deckers, A Hofman, and D.E Grobbee
The prognosis of heart failure in the general population. The Rotterdam Study
Eur. Heart J., August 1, 2001; 22(15): 1318 - 1327.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
E. Grossman, F. H. Messerli, and U. Goldbourt
High Blood Pressure and Diabetes Mellitus: Are All Antihypertensive Drugs Created Equal?
Arch Intern Med, September 11, 2000; 160(16): 2447 - 2452.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. C. Deedwania
Hypertension and Diabetes: New Therapeutic Options
Arch Intern Med, June 12, 2000; 160(11): 1585 - 1594.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Abizaid, G. S. Mintz, A. Abizaid, R. Mehran, A. J. Lansky, A. D. Pichard, L. F. Satler, H. Wu, K. M. Kent, and M. B. Leon
One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 707 - 715.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. S. Abizaid, G. S. Mintz, R. Mehran, A. Abizaid, A. J. Lansky, A. D. Pichard, L. F. Satler, H. Wu, C. Pappas, K. M. Kent, et al.
Long-Term Follow-Up After Percutaneous Transluminal Coronary Angioplasty Was Not Performed Based on Intravascular Ultrasound Findings : Importance of Lumen Dimensions
Circulation, July 20, 1999; 100(3): 256 - 261.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.